• FirefoxInstall the new Firefox »
  •  Dow Up0.86% Nasdaq Up0.90%

    Pacific Biosciences of California, Inc. (PACB)

    6.32 Up 0.02(0.32%) Mar 2, 4:00PM EST
    Add to Portfolio
    ProfileGet Profile for:
    Pacific Biosciences of California, Inc.
    1380 Willow Road
    Menlo Park, CA 94025
    United States - Map
    Phone: 650-521-8000
    Website: http://www.pacificbiosciences.com

    Index Membership:N/A
    Full Time Employees:344

    Business Summary 

    Pacific Biosciences of California, Inc. develops, manufactures, and markets an integrated platform for genetic analysis in the deoxyribonucleic acid (DNA) sequencing market. The company is engaged in developing a single molecule real-time (SMRT) technology for the detection of biological processes. Its SMRT technology is used to study the synthesis, composition, structure, and regulation of DNA, as well as to record individual biochemical events as they occur. The company’s product includes the PacBio RS II high resolution genetic analyzer, an instrument that conducts, monitors, and analyzes single molecule biochemical reactions in real time. Its PacBio RS high resolution genetic analyzer consists of an instrument platform that uses its proprietary consumables, such as SMRT Cells and reagent kits to prepare and sequence DNA samples. The company’s customers include genome centers, genomics service providers, and pharmaceutical and agricultural companies, as well as clinical, government, and academic institutions. Pacific Biosciences of California, Inc. markets its products through a direct sales force in North America and Europe, as well as through distributors in Asia. The company, formerly known as Nanofluidics, Inc., was founded in 2000 and is headquartered in Menlo Park, California.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Pacific Biosciences of California, Inc.

    Corporate Governance 
    Pacific Biosciences of California, Inc.’s ISS Governance QuickScore as of Feb 1, 2015 is 7. The pillar scores are Audit: 1; Board: 9; Shareholder Rights: 6; Compensation: 6.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
    Dr. Michael W. Hunkapiller Ph.D., 66
    Exec. Chairman, Chief Exec. Officer, Pres and Member of Compensation Committee
    Ms. Susan K. Barnes , 61
    Chief Financial Officer and Exec. VP
    Mr. James Michael Phillips , 64
    Sr. VP of R&D
    Mr. Kevin P. Corcoran , 56
    Sr. VP of Market Devel.
    Dr. Stephen Turner Ph.D., 47
    Co-Founder and Chief Technology Officer
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders